DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 94 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,050 | -6.6% | 7,339 | -9.1% | 0.06% | -3.5% |
| Q2 2023 | $96,392 | +53.9% | 8,073 | +72.3% | 0.06% | +67.6% |
| Q1 2023 | $62,638 | -55.1% | 4,685 | -27.7% | 0.03% | -53.4% |
| Q4 2022 | $139,493 | +5.7% | 6,482 | -1.8% | 0.07% | +37.7% |
| Q3 2022 | $132,000 | +12.8% | 6,601 | +0.8% | 0.05% | +23.3% |
| Q2 2022 | $117,000 | +33.0% | 6,551 | -26.3% | 0.04% | +10.3% |
| Q1 2022 | $88,000 | -44.7% | 8,886 | -5.6% | 0.04% | -35.0% |
| Q4 2021 | $159,000 | – | 9,413 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 6,964,301 | $139,495,000 | 56.26% |
| PATHWAY CAPITAL MANAGEMENT, LP | 403,127 | $8,075,000 | 25.88% |
| Atlas Venture Life Science Advisors, LLC | 8,169,171 | $163,628,000 | 18.06% |
| RA Capital Management | 7,040,622 | $141,024,000 | 3.01% |
| COMMODORE CAPITAL LP | 739,661 | $14,815,000 | 2.38% |
| Nicholas Investment Partners, LP | 757,407 | $15,171,000 | 1.41% |
| Boxer Capital, LLC | 1,189,943 | $23,835,000 | 1.34% |
| Parkman Healthcare Partners LLC | 212,191 | $4,250,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $8,012,000 | 0.98% |
| Samsara BioCapital, LLC | 196,425 | $3,934,000 | 0.92% |